Barrier-Forming Antimicrobial Composition for Mucosal Pathogen Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for infectious diseases, particularly those caused by microorganisms like viruses and bacteria, often fail to effectively reduce the duration or severity of symptoms and do not directly kill germs, with many compositions only addressing one type of harmful microorganism, leading to issues like fungal proliferation and limited efficacy due to microbial mutation.
Innovation Solution
A barrier-forming composition comprising a carbohydrate gum, humectant, and antimicrobial agent is applied to mucosal surfaces, forming a long-lasting barrier that traps and kills microorganisms by binding to cell membranes, providing broad-spectrum antimicrobial activity and reducing microbial load.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat infections, then bacterial infections can be treated, but effectiveness is lost due to bacteria mutation and evolution
Solution Approach 1:
The patent converts the harmful effect of microbial cell membranes into a beneficial target for destruction. The antimicrobial agent specifically binds to and disrupts the cell membranes of microorganisms, turning their structural integrity against them to cause cell death, thereby overcoming antibiotic resistance mechanisms
Solution Approach 2:
The patent changes the mechanism of action from conventional antibiotics that target bacterial processes to a physical disruption of cell membrane structure. This parameter change in the mode of action prevents the development of resistance through mutation and evolution, as the membrane disruption mechanism is difficult for microbes to adapt to
2Ease of operation
If symptom-masked treatments are used, then symptoms are relieved, but the body does not recover more quickly and germs are not killed
Solution Approach 1:
The patent merges barrier-forming properties with antimicrobial activity in a single composition. The barrier coating provides physical protection while the incorporated antimicrobial agent simultaneously kills microorganisms, combining symptom relief mechanisms with direct germ killing in one treatment
Solution Approach 2:
The barrier coating creates a self-protecting environment that passively prevents microbial adhesion and infection, while the antimicrobial component provides active destruction of pathogens. This self-service mechanism eliminates the need for continuous external intervention to maintain protection
3Adaptability or versatility
If compositions targeting one group of harmful microorganisms are used, then that specific microorganism is treated, but other groups remain unaffected and fungal microorganisms may proliferate
Solution Approach 1:
The patent creates a universal antimicrobial composition that effectively targets multiple groups of harmful microorganisms including bacteria, viruses, and fungi. The barrier coating combined with the antimicrobial agent provides broad-spectrum protection, preventing any single microorganism type from causing unbalanced proliferation
4Reliability
If a barrier coating is formed on mucosal surfaces, then microbial passage is inhibited, but the barrier must be applied repeatedly to maintain effectiveness
Solution Approach 1:
The barrier coating is designed to provide continuous protection by forming a persistent film on mucosal surfaces. The composition is applied in a manner that ensures the barrier remains intact and functional over an extended period, eliminating the need for frequent reapplication to maintain microbial passage inhibition
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces the duration, frequency, and severity of infectious disease symptoms by creating a sustained antimicrobial barrier that inhibits microbial passage and kills a wide range of pathogens, including viruses, bacteria, and fungi, while being safe and free from harmful side effects.
Implementation Method 1
The barrier-forming composition includes an antimicrobial agent that acts by binding to a cell membrane of the microorganisms and disrupting the cell membrane, thereby causing cell death
Implementation Method 2
Upon administering the composition, the method includes forming a barrier coating on the surface that is active to kill or neutralize microorganisms encountered by the barrier coating
Data Source
AI summary
A method for treating a disease or for treating a symptom of a disease, or a combination of both, the disease being caused or aggravated by microorganisms includes: treating the disease, treating the symptom of the disease, or reducing the duration of the disease, or a combination of both by administering a barrier-forming composition in a therapeutically effective amount to a surface, the surface comprising a mammal mucosa, the mammal being infected with the disease or experiencing symptoms of the disease caused or aggravated by the microorganisms. The barrier-forming composition includes an antimicrobial. Upon administering the composition, the method includes forming a barrier coating on the surface that is active to kill or neutralize microorganisms encountered by the barrier coating. A composition with an agent active for relieving symptoms of a disease is also included.